1. Home
  2. BDSX vs TNMG Comparison

BDSX vs TNMG Comparison

Compare BDSX & TNMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDSX
  • TNMG
  • Stock Information
  • Founded
  • BDSX 2005
  • TNMG 2023
  • Country
  • BDSX United States
  • TNMG Japan
  • Employees
  • BDSX N/A
  • TNMG N/A
  • Industry
  • BDSX Precision Instruments
  • TNMG
  • Sector
  • BDSX Health Care
  • TNMG
  • Exchange
  • BDSX Nasdaq
  • TNMG NYSE
  • Market Cap
  • BDSX 115.4M
  • TNMG 9.2M
  • IPO Year
  • BDSX 2020
  • TNMG N/A
  • Fundamental
  • Price
  • BDSX $0.35
  • TNMG $0.31
  • Analyst Decision
  • BDSX Strong Buy
  • TNMG
  • Analyst Count
  • BDSX 4
  • TNMG 0
  • Target Price
  • BDSX $2.83
  • TNMG N/A
  • AVG Volume (30 Days)
  • BDSX 523.2K
  • TNMG 896.7K
  • Earning Date
  • BDSX 05-13-2025
  • TNMG 05-01-2025
  • Dividend Yield
  • BDSX N/A
  • TNMG N/A
  • EPS Growth
  • BDSX N/A
  • TNMG N/A
  • EPS
  • BDSX N/A
  • TNMG N/A
  • Revenue
  • BDSX $71,323,000.00
  • TNMG N/A
  • Revenue This Year
  • BDSX $32.90
  • TNMG N/A
  • Revenue Next Year
  • BDSX $24.65
  • TNMG N/A
  • P/E Ratio
  • BDSX N/A
  • TNMG N/A
  • Revenue Growth
  • BDSX 45.30
  • TNMG N/A
  • 52 Week Low
  • BDSX $0.45
  • TNMG $0.26
  • 52 Week High
  • BDSX $2.04
  • TNMG $34.08
  • Technical
  • Relative Strength Index (RSI)
  • BDSX 27.69
  • TNMG N/A
  • Support Level
  • BDSX $0.51
  • TNMG N/A
  • Resistance Level
  • BDSX $0.58
  • TNMG N/A
  • Average True Range (ATR)
  • BDSX 0.06
  • TNMG 0.00
  • MACD
  • BDSX -0.01
  • TNMG 0.00
  • Stochastic Oscillator
  • BDSX 1.15
  • TNMG 0.00

About BDSX Biodesix Inc.

Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.

About TNMG TNL MEDIAGENE

TNL Mediagene is a comprehensive media and data platform providing news and commentary on current events, business, technology, lifestyle and sports.

Share on Social Networks: